To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
News | Epigenetics
Biologists have brought to light the operation of "chromatin remodellers", key enzymes in cells. They have discovered how the genetic material, condensed in the nucleus of the cell, needs to be remodelled so that the cell machinery can access the genes. This work, initiated by IBITECS/SBIGeM, coordinated by researchers from a CEA/CNRS/Université Paris-Sud laboratory, under an international collaborative project with Pennsylvania State University (USA) and Guangzhou University (China), was published in Nature on 4 February 2016.
Our genome, "condensed" into a nucleus of a only a few tens of microns, comprises about 30,000 genes. This compaction is made possible by its organisation as chromatin – "beads on a string" of nucleosomes comprising genomic DNA wound around a protein core. But this nucleosome structure poses numerous problems for the cell, because the DNA is rendered inaccessible to most of the enzymes, in particular the RNA polymerase, responsible for RNA genome transcription, ahead of the protein synthesis necessary for expressing cell identity and function.
This is when the chromatin remodellers come into play. Their function in opening up the chromatin, to make the DNA accessible, was already known, but researchers were unaware of how they worked. In this study, the authors demonstrate that the remodellers bind to precise nucleosomes, situated on either side of the start site (called the promoter) of each gene (see figure). The remodellers work by imposing a constant dynamic on the nucleosomes to which they bind, which play an active role in regulating the genome by allowing recruitment of the enzymes responsible for transcription.
© Matthieu Gérard / CEA
Correct gene expression is necessary to define the identity and function of the cells during embryo development and adult life. Fewer than one quarter of the genes are expressed uniformly in all the cells of the organism; the other more specialised genes are necessary and expressed only in certain tissues and certain specific cells. Each cell type is thus faced with the enormous challenge of correctly expressing each of its genes. Numerous cell mechanisms are involved in achieving this goal, with the remodellers taking part by promoting or inhibiting DNA accessibility at the start sites of the genes.
de Dieuleveult M, Yen K, Hmitou I, Depaux A, Boussouar F, Bou Dargham D, Jounier S, Humbertclaude H, Ribierre F, Baulard C, Farrell NP, Park B, Keime C, Carrière L, Berlivet S, Gut M, Gut I, Werner M, Deleuze JF, Olaso R, Aude JC, Chantalat S, Pugh BF, Gérard M (2016) Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells. Nature, 530, 113–116 http://dx.doi.org/10.1038/nature16505
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.